Womens Sexual health – PT141 Peptide
PT-141 increases sexual desire and arousal without affecting hormones—ideal for women facing low libido or intimacy challenges.
Improve Your Sexual Wellness
PT-141 (Bremelanotide) is a non-hormonal peptide treatment that stimulates sexual desire and arousal by acting directly on the brain’s melanocortin receptors. Unlike therapies that rely on hormone levels or blood flow, PT-141 targets the nervous system—helping boost libido, sensitivity, and sexual satisfaction for women at any stage of life.
It’s particularly effective for those experiencing low desire, difficulty with arousal, or sexual dysfunction related to stress, aging, or hormonal shifts. Administered as a subcutaneous injection 30–60 minutes before intimacy, PT-141 can work within the hour, with effects lasting up to 24 hours. Many women feel more confident, emotionally connected, and in tune with their partner after using it.
FAQ
PT-141 (Bremelanotide) is a peptide used to enhance sexual desire and arousal in women. Unlike other medications that work through hormonal pathways or blood flow, PT-141 acts directly on the brain’s melanocortin receptors to stimulate libido naturally.
PT-141 targets the central nervous system, specifically the hypothalamus, which regulates sexual desire. By activating these receptors, PT-141 helps increase sexual interest, arousal, and sensitivity—without relying on hormone levels.
- Increased sexual desire and arousal
- Improved vaginal lubrication and sensitivity
- Enhanced sexual satisfaction
- Helps women with HSDD (Hypoactive Sexual Desire Disorder)
Works independently of estrogen or testosterone levels
PT-141 is typically administered as a subcutaneous injection (usually in the abdomen or thigh), about 30 to 60 minutes before sexual activity. Some patients report benefits lasting up to 12–24 hours.
It can be used as needed, but most practitioners recommend 1–3 times per week depending on individual response and goals. Your provider will guide you on frequency during your treatment plan.
PT-141 has been shown to be safe and well-tolerated. It’s FDA-approved under the brand name Vyleesi for premenopausal women with HSDD. Side effects are typically mild and transient.
- Nausea (most common, usually mild and short-lived)
- Flushing or warmth
- Headache
- Slight increase in blood pressure (temporary)
Injection site redness
Yes. PT-141 can be part of a comprehensive approach to sexual wellness, often paired with:
- Hormone therapy (if indicated)
- Oxytocin nasal spray
- O-shot or PRP therapy
- Lifestyle and stress support
- Functional medicine to address root causes (thyroid, gut, cortisol)
Women who experience:
- Low libido or lack of sexual desire
- Difficulty with arousal or orgasm
- Sexual dysfunction due to stress, hormonal shifts, or aging
Little benefit from hormonal or topical interventions
are excellent candidates for PT-141.
While FDA-approved for premenopausal women, PT-141 is commonly and safely used off-label in postmenopausal women, especially as part of an integrative or functional medicine plan.
Many women report noticeable effects within 30–60 minutes of their first dose. Consistent use over time may further improve sexual response and confidence.
No, PT-141 is non-hormonal. It does not raise estrogen or testosterone levels—it works neurologically by enhancing desire through brain receptors.
Absolutely. Many women feel more confident, connected, and emotionally in tune after addressing physical sexual response. PT-141 may also reduce performance anxiety or mental blocks around intimacy.
PT-141 is available by prescription and should be obtained through a licensed medical provider. At TONIIK, we offer medical-grade PT-141 therapy as part of our personalized sexual wellness programs.
